evaluate the pharmaceuticals company zepbound on glp-1 efficacy / effectiveness A 72-week trial compared two leading medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Betting on GLP-1 - by

Across more than 100 preclinical publications many from a single research group led by Sikiri and colleagues the peptide has demonstrated healing effects on tendon, muscle, bone, nerve, and gut tissue, often with no reported acute toxicity even at doses far exceeding those proposed for practical use

Grand challenges in pharmaceutical research series: ridding the cold chain for biologics

Step One: The body combines glutamate and cysteine

doi: 10.1016/j.bbrc.2021.05.095 370 PengJPanJMoJPengY

The induction of oxalate metabolism in vivo is more effective with functional microbial communities than with functional microbial species

Proposals for compounding reform are under consideration in California, Colorado and Kentucky